We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Anesthetics May Aggravate Alzheimer's Disease

By HospiMedica staff writers
Posted on 23 Nov 2006
A new study has found that certain general anesthetics could increase the risk of elderly patients developing Alzheimer's disease and other memory and attention problems.

Researchers at the University of Pittsburgh Medical School (PA, USA) conducted a series of animal studies and test tube experiments which have revealed that the inhaled anesthetics halothane and isoflurane encourage the binding of beta amyloid proteins. More...
This binding forms clumps or "plaques” that are characteristic of Alzheimer's disease and may contribute to brain cell death. This effect was also shown with the commonly used intravenous anesthetic propofol, at least at higher concentrations. The findings back up a previous study in which the same researchers used nuclear magnetic resonance (NMR) spectroscopy to show that halothane interacts directly with a pocket in the beta amyloid protein, changing its shape and encouraging neighboring proteins to bind. Just six hours of exposure to halothane is sufficient to trigger protein clumping similar to that seen in people with Alzheimer's.

Although halothane is rarely used in North America or Europe, it is commonly used in Asia and Africa because it is very cheap. The other anesthetics studied are more widely used in the United States and Europe, often in combination, although these seem to take longer to exert their potentially deadly effects. The good news is that the intravenous anesthetic thiopental--also known as thiopentone--appears to have no effect on the proteins. The study was presented at the 2007 annual meeting of the Society for Neuroscience held in Atlanta (GA, USA) in October 2006.

"It is a seriously deadly combination when an older person receives halothane,” said lead author Dr. Pravat Mandal, an assistant professor in the department of psychiatry and the center for neuroscience at the University of Pittsburgh, "because as we get older we all have more beta amyloid in our brains.”

The link between surgery and cognitive problems was first noted during the 1950s, but it was never clear whether postoperative cognitive dysfunction (POCD) was the result of the surgery itself or the anesthetics.



Related Links:
University of Pittsburgh Medical School

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.